Drugs News and Research

RSS

PNNL ScalaBLAST may be used to process complex genomic sequences

A new computational tool developed at the Department of Energy's Pacific Northwest National Laboratory is speeding up our understanding of the machinery of life - bringing us one step closer to curing diseases, finding safer ways to clean the environment and protecting the country against biological threats.

21 Jun 2005

Researchers develop method that can help doctors choose the best combination of drugs for fighting cancer

The method is based on a mathematical model that determines when a cancer becomes drug-resistant during therapy. It does this by estimating the probability of finding drug-resistant mutant cells at different stages of cancer progression and examining the fate of individual mutant colonies during therapy.

21 Jun 2005

Insulin resistance drug with anti-inflammatory effects reduces risk factors

A drug, which reduces insulin resistance and also may have anti-inflammatory and other effects on blood vessels, lowered cardiovascular risk factors in patients with diabetes more than another diabetes medicine, even though both drugs improved blood sugar control equally, according to a new study (PDF) in the June 21, 2005, issue of the Journal of the American College of Cardiology.

21 Jun 2005

Worldwide cost of Alzheimer's disease and dementia estimated at $156 billion

The first estimate of the worldwide direct costs of Alzheimer’s disease and dementia care was released at the Alzheimer’s Association International Conference on the Prevention of Dementia. As a result, scientists, advocates and those affected by the disease are calling for increased funding for research and support services.

21 Jun 2005

Evidence grows for change in cannabis laws

Studies linking cannabis use to mental illnesses and addictive drugs such as heroin are compelling reasons for the State Government to revise its soft-on-drugs legislation, the Australian Medical Association (WA) said today.

21 Jun 2005

Pioneering new thyroid treatment

The doctor has developed a revolutionary technique for treating hyperthyroidism, also known as Graves' Disease. And earlier this month, Culham became the first person in North America to undergo the new procedure.

21 Jun 2005

First new treatment for Elephantiasis (lymphatic filariasis)

Scientists at the Liverpool School of Tropical Medicine have proved that a single course of one antibiotic may hold the key to curing the parasitic worm disease Elephantiasis (lymphatic filariasis) that has been one of the most common causes of global disability since Biblical times.

21 Jun 2005

Researchers isolate substance most responsible for the tissue damage that follows initial spinal cord injury

Purdue University researchers may have isolated the substance most responsible for the tissue damage that follows initial spinal cord injury, a discovery that could also improve treatments for a host of other neurodegenerative conditions.

21 Jun 2005

Safety warning on Internet drugs

Thousands of men in the UK buy “lifestyle drugs” such as erectile dysfunction medication, weight and hair loss products from websites and are oblivious to the fact that some (not all) of the websites belong to unscrupulous vendors.

21 Jun 2005

WHO says AIDS fight will only be won with generic drugs

According to the World Health Organisation (WHO) the key to AIDS treatment in the developing world is generic drugs, but the target of 3 million people on therapy by the end of 2005 may now be unattainable.

21 Jun 2005

Vascular disease most common cause of male erectile dysfunction

A preeminent cardiologist reports, for the first time in a large prospective study, that certain of his patients with erectile dysfunction (ED) and heart problems can now safely use erection drugs that help up to 80% of men restore function and quality of life.

21 Jun 2005

Software that automatically assesses a drug's effect on nerve cells

Potential new drugs for neurological disorders like Parkinson's are being screened faster thanks to world-leading CSIRO software that automatically assesses a drug's effect on nerve cells.

21 Jun 2005

Thalidomide may be a potent anti-cancer treatment

When people hear "thalidomide," many think "birth defects," however, evidence has come to light that this once-banned drug can be used as a potent anti-cancer treatment.

20 Jun 2005

Australian researchers at the forefront of an international project to identify genes associated with schizophrenia

University of Queensland researchers are at the forefront of an international project to identify genes associated with schizophrenia, a common mental illness whose causes are not fully understood.

20 Jun 2005

FDA severely limits access to cancer drug Iressa

After Food and Drug Administration (FDA) officials agreed with studies showing lung cancer drug, Iressa, did not help patients live longer, drug company AstraZeneca said it would severely limit access to its drug.

20 Jun 2005

China used flu drug on birds

The World Health Organization (WHO) is attempting to clarify from China, reports that the government there encouraged farmers to use a human anti-viral drug to treat birds infected with a deadly strain of avian flu.

20 Jun 2005

Drug for schizophrenia can prevent and treat SARS

Chinese and European experts at a conference of the Sino-European Project on SARS Diagnostics and Antivirals in China say that a drug normally used to treat schizophrenia has been shown to prevent and treat Severe Acute Respiratory Syndrome (SARS).

20 Jun 2005

Studies show Alzheimer's prevented by drinking juice daily and having the occasional alcoholic drink

At a conference in the U.S. on Alzheimer's disease on June 19, researchers said that they think brain scans and simple blood tests may offer the best ways to predict who has the highest risk of Alzheimer's disease.

20 Jun 2005

Brazil patent seizure threatens global trade and public health

With a number of other non-profit groups, ITSSD is calling attention to Brazil's threat to break U.S. patents on American AIDS drugs used as part of Brazil's government-funded treatment program.

19 Jun 2005

Fine tuning drug levels in neuroblastoma patients is effective

Monitoring and fine tuning the levels of the cancer drug topotecan in children with neuroblastoma holds promise for maximizing the drug's effectiveness while reducing its toxicity, according to investigators at St. Jude Children's Research Hospital.

19 Jun 2005